Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Dollar General
DG
$27.1B
| $132M | 0.07% |
1,210,669
+169,688
| +16% | +$17.6M |
|
327
Trinity Industries
TRN
$2.94B
| $132M | 0.07% |
5,002,085
-912,659
| -15% | -$23.9M |
|
|
CONE
328
DELISTED
CyrusOne Inc Common Stock
CONE
| $131M | 0.07% |
2,059,062
+274,885
| +15% | +$17.8M |
|
|
EGRX
329
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $130M | 0.07% |
1,881,501
-9,797
| -0.5% | -$743K |
|
330
D.R. Horton
DHI
$41.6B
| $129M | 0.07% |
3,065,946
-1,219,980
| -28% | -$52.8M |
|
|
MDSO
331
DELISTED
Medidata Solutions, Inc.
MDSO
| $129M | 0.07% |
1,762,023
-142,071
| -7% | -$11.4M |
|
|
DCP
332
DELISTED
DCP Midstream, LP
DCP
| $129M | 0.07% |
3,252,411
-93
| -0% | -$3.91K |
|
333
PagSeguro Digital
PAGS
$2.62B
| $129M | 0.07% |
4,647,944
+3,373,784
| +265% | +$91.8M |
|
334
Avnet
AVT
$7.24B
| $126M | 0.07% |
2,816,660
-170,811
| -6% | -$7.84M |
|
|
BHVN
335
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $125M | 0.07% |
3,336,916
+37,616
| +1% | +$1.38M |
|
336
United Rentals
URI
$70B
| $125M | 0.07% |
761,504
-234,237
| -24% | -$36.5M |
|
337
Ralph Lauren
RL
$22.7B
| $124M | 0.07% |
903,894
+16,265
| +2% | +$2.17M |
|
|
GBT
338
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $124M | 0.07% |
3,268,038
-886,347
| -21% | -$39.3M |
|
339
LKQ Corp
LKQ
$6.67B
| $122M | 0.07% |
3,851,179
-830,797
| -18% | -$27.6M |
|
340
Icon
ICLR
$13B
| $121M | 0.06% |
788,206
+37,851
| +5% | +$5.43M |
|
341
MarketAxess Holdings
MKTX
$4.17B
| $121M | 0.06% |
677,628
-2,707
| -0.4% | -$520K |
|
342
IBM
IBM
$206B
| $121M | 0.06% |
836,503
+571,182
| +215% | +$79.8M |
|
|
TIF
343
DELISTED
Tiffany & Co.
TIF
| $120M | 0.06% |
931,173
+140,021
| +18% | +$18.3M |
|
344
Akamai
AKAM
$16.6B
| $120M | 0.06% |
1,640,017
+477,914
| +41% | +$35.9M |
|
345
M&T Bank
MTB
$36.4B
| $120M | 0.06% |
727,518
+371,263
| +104% | +$64.4M |
|
346
Omnicell
OMCL
$1.9B
| $120M | 0.06% |
1,662,720
+148,741
| +10% | +$9.37M |
|
347
Newmont
NEM
$98.4B
| $119M | 0.06% |
3,948,762
+350,156
| +10% | +$11.8M |
|
|
NUVA
348
DELISTED
NuVasive, Inc.
NUVA
| $119M | 0.06% |
1,674,726
-414,324
| -20% | -$26.4M |
|
349
Arista Networks
ANET
$215B
| $119M | 0.06% |
7,136,320
+346,896
| +5% | +$5.9M |
|
350
Nutrien
NTR
$32.1B
| $118M | 0.06% |
2,050,841
+73,135
| +4% | +$4.05M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.